Response from Bev-
Let me try to address some of your concerns -- first of all, a business plan on a website is not a good idea at all. It provides information to competitors and frankly, all business plans that I have ever seen require a note of confidentiality to be signed on them. That being said, I can assure you that the company has been working very hard on its cancer product lines -- although you are not seeing "press releases" on a daily basis - that simply means that some activities may not as yet be completed or they may not be allowed to be announced (there are occasions when this is the case).

It is no secret that Lifeline, as a pink sheet company, is a very risky investment -- however I know they are working on steps to move to the bulletin board (it is the only exchange at this time where they meet the requirements such as a minimum bid price - if the share price were higher, I'm sure they would consider the AMEX or NASDAQ).

One of the primary steps for this is the completion of the audit, which is taking place right now. Once the audit is completed, the form 10K (which is a registration statement) will be filed with the SEC, who then has I think 90 days in which to review the filing. If there are no "comments" or "questions" from the SEC, then the 10K is declared effective and the company is a reporting company - the first step toward moving off the pinks.

I hope this helps - more specific questions would be helpful at my end.

Bev Jedynak

Beverly Jedynak
President
Martin E. Janis & Company, Inc.
Public Relations
625 North Michigan Avenue, Suite 420
Chicago, IL 60611
312-943-1100 ext 12
312-943-3583 (fax)
bjedynak@janispr.com

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Dec. 2, 2004--Lifeline Biotechnologies, Inc. (OTC:LBTN - News) today announced that the September/October 2004 issue of the International Journal of Fertility and Women's Medicine, a peer-reviewed, indexed journal read by physicians and researchers involved in women's health, contains several articles authored by doctors who have been involved in research in connection with Lifeline's breast ductoscopy product, the MastaScope(TM).
Among the articles in this issue are two that specifically refer to issues relating to breast cancer that comprise the market for the MastaScope. In one article (Int J Fertil Vol. 49, No. 5, pp 200-203), Drs. Clare Leris and Kefah Mokbel of St. George's Hospital in London discuss the use of mammary ductoscopy in the assessment of breast disease. As the abstract to the article states: "...Mammary ductoscopy is a useful diagnostic adjunct in patients with pathological nipple discharge." The article notes that further research is needed to determine the potential use in the early detection of breast cancer, guiding breast conserving surgery for cancer, therapeutic ablation of intraductal disease and guiding risk-reducing strategies among high risk women. It also notes that future developments in the area include the development of a biopsy kit and combining mammary ductoscopy with molecular diagnostic markets and real-time optical biopsy systems for the diagnosis of premalignant and early malignant disease and radio frequency for curative ablation of intraductal lesions.

In a second article in the same issue (Int J Fertil Vol. 49, No. 5, pp 222-224), Dr. Pedro F. Escobar, MD., Deborah Baynes, PA and Dr. Joseph P. Crowe, of the Department of General Surgery-Breast Center at The Cleveland Clinic Foundation in Cleveland, Ohio, discuss the results of some 40 cases in which they have examined the ductal system of the breast using mammary ductoscopy or direct visualization of the ducts in vivo. In this report, the doctors discuss how ductoscopy was used to guide the infusion of methylene blue dye, through the endoscope, to find the index duct, which is then removed through a small incision just inside the areola. Until 10 years ago, examination of the ductal system of the breast required excision of all of the major ducts, in a block of tissue.

Drs. Mokbel and Escobar are both involved in on-going studies using Lifeline's MastaScope.

Lifeline Biotechnologies, Inc. is a company with innovative medical technologies committed to the improvement of the quality of life through exceptional health care systems. These technologies focus on prevention, early detection, diagnosis and quick recovery of a number of disease conditions. The company's cancer detection technologies deal with cutting edge innovation to assist practicing physicians to deliver quality medical care. The MastaScope(TM) is used in the early detection of cancer and other abnormalities of the breast. The MastaScope(TM) has completed development and has entered the marketplace in the US and internationally. The company is also developing the OvaScope(TM), a product that can be used in the early detection of ovarian cancer and its First Warning System, a non-invasive means of detecting breast cancer. More information is available at the company's website: www.lbti.com. The company does not endorse, nor is it connected in any way with any other websites found on the Internet.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, when used in the preceding discussion, the words "believe", "expects", "projects", "forecasts", "intends", "will", "anticipated", "could", or "may" and similar conditional expressions are intended to identify the forward-looking statements within the meaning of the act and are subject to the safe harbor created by the act. Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements that involve a number of risks and uncertainties.

--------------------------------------------------------------------------------
Contact:
Martin E. Janis & Company, Inc.
Bev Jedynak, 312-943-1100 ext. 12
bjedynak@janispr.com

I use to own a turd load of this stock! I had 2.76+ million shares until the co. bent us over and now I have 18,414 shares. On TheLBTTSpot website there is a guy called Ranger who has his own investment co. with most of his customers owning LBTN. He says he is in contact with management and they tell him that word on the audit will be out any day now. How long have we been hearing this??? I hope it's true though. He also says Lifeline is telling him that they're getting financing real soon. Again we shall see. Well good luck to you and anyone else that owns this turd!

quote:

---

Originally posted by BB:
cowboy,

I use to own a turd load of this stock! I had 2.76+ million shares until the co. bent us over and now I have 18,414 shares. On TheLBTTSpot website there is a guy called Ranger who has his own investment co. with most of his customers owning LBTN. He says he is in contact with management and they tell him that word on the audit will be out any day now. How long have we been hearing this??? I hope it's true though. He also says Lifeline is telling him that they're getting financing real soon. Again we shall see. Well good luck to you and anyone else that owns this turd!

BB

---

This is from Ranger at the thelbttspot message board. He posted this yesterday. I hope something happens quick because the share price is down to .125.

BB

I was told that ALL the data necessary was submitted to the auditor a few weeks ago. The audit shold be complete very soon. As I told senior management at LBTN, "my company has a larger capitalization than LBTN and I can have a total audit done in less than 7 days, that covers all of my locations in over 16 countries. Get real, it does not take this long to do an SEC audit." They agreed!

I am waiting on the audit , just like all the others, but I am giving management input on how to move the audit process along more quickly.

quote:

---

Originally posted by BB:
Cowboy,

This is from Ranger at the thelbttspot message board. He posted this yesterday. I hope something happens quick because the share price is down to .125.

BB

I was told that ALL the data necessary was submitted to the auditor a few weeks ago. The audit shold be complete very soon. As I told senior management at LBTN, "my company has a larger capitalization than LBTN and I can have a total audit done in less than 7 days, that covers all of my locations in over 16 countries. Get real, it does not take this long to do an SEC audit." They agreed!

I am waiting on the audit , just like all the others, but I am giving management input on how to move the audit process along more quickly.

Ranger7

---

I've lost so much now that it wouldn't be worth bailing out. I'm stuck holding and now praying for a miracle to happen. Our father... If the audit is ever complete - I think it will keep the ship floating for a bit longer. Now if the audit and a financing deal comes out it should bring the price up. How high no one knows - but it should give some faith to the share holders about the co. I guess it depends on how much funding they get. Those are a lot of big ifs. I think I'll go buy some lottery tickets because I'll have a better chance making money with them.

quote:

---

Originally posted by BB:
Cowboy,

I've lost so much now that it wouldn't be worth bailing out. I'm stuck holding and now praying for a miracle to happen. Our father... If the audit is ever complete - I think it will keep the ship floating for a bit longer. Now if the audit and a financing deal comes out it should bring the price up. How high no one knows - but it should give some faith to the share holders about the co. I guess it depends on how much funding they get. Those are a lot of big ifs. I think I'll go buy some lottery tickets because I'll have a better chance making money with them.

BB

---